cours de bourse
14/08/2009 - 11:07:23|49.66 EUR 0.42 %
ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue...
ORALAIR® (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue...
Drawing on its in-depth knowledge of allergic diseases, and its unique expertise in allergy immunotherapy (AIT), Stallergenes Greer thereby offers a comprehensive approach to improving the lives of allergy patients.
Patient expectations are at the core of Stallergenes Greer innovation strategy.
World leader in sublingual immunotherapy, Stallergenes Greer provides efficient and patient-friendly allergy immunotherapy treatment options, such as shorter protocols to reduce the duration of treatment and the new convenient tablet form.